Cargando…
Octreotide Infusion for the Treatment of Congenital Chylothorax
Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have b...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673913/ https://www.ncbi.nlm.nih.gov/pubmed/33224547 http://dx.doi.org/10.1155/2020/8890860 |
_version_ | 1783611413015560192 |
---|---|
author | Kobeisy, Sumayyah Ahmed Nezar Alkhotani, Abdulaziz Barzanji, Mohammed M. |
author_facet | Kobeisy, Sumayyah Ahmed Nezar Alkhotani, Abdulaziz Barzanji, Mohammed M. |
author_sort | Kobeisy, Sumayyah Ahmed Nezar |
collection | PubMed |
description | Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have been published so far regarding the management of congenital chylothorax in the neonate, but trials of octreotide have appeared to be promising (Bellini et al., 2018). We present a neonate with congenital chylothorax successfully treated with octreotide infusion. |
format | Online Article Text |
id | pubmed-7673913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-76739132020-11-19 Octreotide Infusion for the Treatment of Congenital Chylothorax Kobeisy, Sumayyah Ahmed Nezar Alkhotani, Abdulaziz Barzanji, Mohammed M. Case Rep Pediatr Case Report Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have been published so far regarding the management of congenital chylothorax in the neonate, but trials of octreotide have appeared to be promising (Bellini et al., 2018). We present a neonate with congenital chylothorax successfully treated with octreotide infusion. Hindawi 2020-11-11 /pmc/articles/PMC7673913/ /pubmed/33224547 http://dx.doi.org/10.1155/2020/8890860 Text en Copyright © 2020 Sumayyah Ahmed Nezar Kobeisy et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Kobeisy, Sumayyah Ahmed Nezar Alkhotani, Abdulaziz Barzanji, Mohammed M. Octreotide Infusion for the Treatment of Congenital Chylothorax |
title | Octreotide Infusion for the Treatment of Congenital Chylothorax |
title_full | Octreotide Infusion for the Treatment of Congenital Chylothorax |
title_fullStr | Octreotide Infusion for the Treatment of Congenital Chylothorax |
title_full_unstemmed | Octreotide Infusion for the Treatment of Congenital Chylothorax |
title_short | Octreotide Infusion for the Treatment of Congenital Chylothorax |
title_sort | octreotide infusion for the treatment of congenital chylothorax |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673913/ https://www.ncbi.nlm.nih.gov/pubmed/33224547 http://dx.doi.org/10.1155/2020/8890860 |
work_keys_str_mv | AT kobeisysumayyahahmednezar octreotideinfusionforthetreatmentofcongenitalchylothorax AT alkhotaniabdulaziz octreotideinfusionforthetreatmentofcongenitalchylothorax AT barzanjimohammedm octreotideinfusionforthetreatmentofcongenitalchylothorax |